AIkido Pharma (AIKI) News Today $6.25 -0.22 (-3.40%) As of 08/28/2025 Add Compare Share Share Headlines Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock AIKI Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period AIkido Pharma (NASDAQ:AIKI) Stock Price Crosses Above Two Hundred Day Moving Average - Here's WhyAugust 21, 2025 | americanbankingnews.comCrypto, Real Estate, And More: The Lesser-Known 'Dealmakers' Behind Trump’s $5 Billion EmpireAugust 20, 2025 | msn.comHow an Obscure Firm Bet on the Trumps and Became Their Go-To DealmakerAugust 19, 2025 | msn.comDon Jr. And Eric Trump Could Soon Sell $9.6 Million In Stock Granted For Brief Advisory Board Tenure, SEC Filing RevealsApril 26, 2025 | msn.comDon Jr. And Eric Trump Landed $3 Million In Stock For Joining Firm’s Advisory Board That Had Little Public Presence Before Their AppointmentApril 17, 2025 | msn.comTrump Sons Joined Dominari Holding’s Advisory Board–But There’s Little Public Record The Board Existed BeforehandMarch 7, 2025 | forbes.comDon Jr. and Eric Trump invest in small biotech turned fintech based in Trump Tower, sending stock skywardFebruary 12, 2025 | msn.comDominari Holdings Inc trading resumesFebruary 12, 2025 | markets.businessinsider.comSNOA Sonoma Pharmaceuticals, Inc.March 17, 2024 | seekingalpha.comRoyalty Pharma PLCJanuary 23, 2024 | wsj.comKengan Ashura: 10 Strongest Fighters, RankedOctober 6, 2023 | msn.comDominari Holdings Inc. Releases Shareholder UpdateSeptember 6, 2023 | markets.businessinsider.comKyle Wool Appears on Fox BusinessApril 10, 2023 | markets.businessinsider.comDominari Holdings Appoints George Way As CFOApril 3, 2023 | markets.businessinsider.comDominari Financial Inc. Acquires Leading Broker Dealer and Registered Investment Advisor BusinessMarch 27, 2023 | markets.businessinsider.comDominari Financial Granted Approval to Acquire Broker DealerMarch 21, 2023 | benzinga.comDominari Holdings Provides Business UpdateMarch 14, 2023 | finance.yahoo.comDominari Holdings Provides Update on Share Repurchase ProgramDecember 28, 2022 | finance.yahoo.comAIkido Pharma Inc.: AIkido Pharma Announces Successful Initial Public Offering of ASP IsotopesDecember 22, 2022 | finanznachrichten.deAIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)December 22, 2022 | finance.yahoo.comAIkido Pharma Announces Successful Initial Public Offering of ASP IsotopesNovember 28, 2022 | finance.yahoo.comAIkido Share Repurchase ContinuesOctober 6, 2022 | finance.yahoo.comAIkido Purchases More SharesOctober 5, 2022 | finance.yahoo.comShare Repurchase Program ContinuesOctober 4, 2022 | finance.yahoo.comAIkido Pharma Continues Share Repurchase ProgramOctober 3, 2022 | finance.yahoo.comAIkido Pharma Provides Update on Share Repurchase ProgramSeptember 30, 2022 | finance.yahoo.comDominari Financial, Inc. Executes Definitive Agreement to Buy Broker-DealerSeptember 9, 2022 | prnewswire.comPre-Open Movers: Nielsen Climbs 20%, AppLivin Makes Offer for UnityAugust 10, 2022 | ca.investing.comAIkido Pharma Gets $8/Share Buyout Offer From Shalom Auerbach >AIKIAugust 10, 2022 | marketwatch.comAIkido Pharma Receives Offer From Shalom Auerbach - Quick FactsAugust 10, 2022 | nasdaq.comAIkido Pharma Confirms Receipt of Unsolicited OfferAugust 10, 2022 | finance.yahoo.comInvestor Makes Proposal to Acquire AIkido Pharma for $8.00 Per Share in CashAugust 9, 2022 | finance.yahoo.comAikido Pharma IncAugust 7, 2022 | reuters.comAIkido Pharma, Inc. Hires Carlos Aldavero to Lead Financial Services SubsidiaryJuly 21, 2022 | finance.yahoo.comAIkido Pharma regains Nasdaq complianceJune 30, 2022 | seekingalpha.comAIkido Inc. Announces the Formation of a New Financial Services SubsidiaryJune 24, 2022 | finance.yahoo.comSignificant Investor in AIkido Pharma Urges Board to Commit to Sell Assets and Return Capital to StockholdersJune 21, 2022 | finance.yahoo.comAIkido Pharma Inc. Appoints New Director, Soo YuJune 10, 2022 | finance.yahoo.comSignificant Investor in AIkido Pharma Issues Open...June 9, 2022 | benzinga.comAIkido Pharma stock falls again after reverse stock split takes effectJune 8, 2022 | morningstar.comMSignificant Investor in AIkido Pharma Issues Open Letter to Board of DirectorsJune 7, 2022 | finance.yahoo.comWhy Is AIkido Pharma (AIKI) Stock Up 1,400%?June 7, 2022 | investorplace.comAIkido Pharma Approves Reverse Stock Split; Stock FallsJune 5, 2022 | marketwatch.comAlkido Pharma announces 1-for-17 reverse stock splitJune 3, 2022 | seekingalpha.comAIkido Announces Reverse Stock SplitJune 3, 2022 | finance.yahoo.comAIkido Pharma Announces Company Commitment to Board DiversityMay 19, 2022 | finance.yahoo.comAIkido Pharma Secures Interest in Databricks Inc.May 12, 2022 | finance.yahoo.comAIkido Pharma (NASDAQ:AIKI) Is In A Good Position To Deliver On Growth PlansMay 11, 2022 | finance.yahoo.comAIkido Reports Slinger Bag Inc.'s Filing for Nasdaq Public ListingMay 5, 2022 | finance.yahoo.comAIkido Pharma Announces Strategic Investment in Social Communications Platform Provider Discord, Inc.May 4, 2022 | finance.yahoo.com Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AIKI Media Mentions By Week AIKI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AIKI News Sentiment▼0.001.03▲Average Medical News Sentiment AIKI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AIKI Articles This Week▼00▲AIKI Articles Average Week Get the Latest News and Ratings for AIKI and Related Stocks Enter your email address to receive the latest news and analysts' ratings for AIkido Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Luna Innovations News BioHarvest Sciences News Coherus Oncology News CareCloud News Anteris Technologies Global News Zura Bio News Jin Medical International News Oncobiologics News Anika Therapeutics News Zentalis Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AIKI) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access